<DOC>
	<DOCNO>NCT01433263</DOCNO>
	<brief_summary>A safety &amp; efficacy clinical study investigational medicinal product BYM338 treatment unintentional weight loss patient cancer lung pancreas</brief_summary>
	<brief_title>Clinical Study BYM338 Treatment Unintentional Weight Loss Patients With Cancer Lung Pancreas</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Antibodies , Blocking</mesh_term>
	<criteria>Key Inclusion criterion : 1 . Patients must sign informed consent assessment 2 . Patients pathologically and/or clinically confirm diagnosis stage IV nonsmall ( squamous nonsquamous ) cell lung cancer ( NSCLC ) stage III/IV adenocarcinoma pancreas . 3 . Patients stage IV NSCLC receive complete discontinued standard chemotherapy chemotherapynaive choice . 4 . Patients stage III/IV pancreatic adenocarcinoma receive standard chemotherapy chemotherapy . If patient receive chemotherapy , change chemotherapy expect . 5 . Greater equal 5 % unintentional weight loss previous 36 month , explain simple starvation . Simple starvation consider exclude weight loss ameliorate standard nutritional counseling oral supplementation 2 week period . 6 . Body mass index ( BMI ) â‰¤ 30 kg/m2 . 7 . Life expectancy least 4 month . 8 . Able communicate well comply requirement study , include phone write log . Key Exclusion criterion : 1 . Patients receive investigational antineoplastic therapy within 3 week screen 2 . Evidence inadequate organ brain function , define lab test image 3 . Patients severe and/or uncontrolled medical condition could interfere study ( e.g . heart condition , high blood pressure , diabetes , infection ) uncontrolled pain nonstable illness 4 . Pregnant lactating woman . 5 . Women capable become pregnant must use highly effective contraception study 8 week stop treatment . All female patient must negative pregnancy test result throughout study 6 . Patients unwilling unable follow instruction . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Wasting syndrome</keyword>
	<keyword>emaciation</keyword>
	<keyword>lung cancer</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>pancreatic cancer</keyword>
</DOC>